Thursday, January 20, 2022 1:42:27 PM
The immuneactive will be a decent revenue stream, people are scrambling to try anything these days to help their immune systems during the ongoing Covid pandemic.
What people are sleeping on yet again is the animal / veterinary market, which is absolutely massive. By end of year they said they expect animal mAbs for various types of illnesses / diseases to be rolled out. These don’t need trials like human meds. Like I’ve said before, most people don’t realize how huge that is going to be. Personal pets, Vets, zoos, farms, list goes on and on. That market is bigger than people can fathom.
Besides, bios do not need to be completely to market to see huge payoffs. Multiple clinical trials will also be underway this year.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
ECGI Holdings Targets $9.7 Billion Equestrian Apparel Market with Allon Brand Launch • ECGI • Jun 25, 2024 8:36 AM
Avant Technologies Addresses Progress on AI Supercomputer-Driven Data Centers • AVAI • Jun 25, 2024 8:00 AM
Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai • GRLF • Jun 24, 2024 8:30 AM